SCHEMBL27006191

SCHEMBL27006191

CCC1(OC(=O)c2ccccc2O)CCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
TSHR P16473 2/20 0.49
TDP1 Q9NUW8 2/20 0.45
ALDH1A1 P00352 4/20 0.44
CYP3A4 P08684 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
HPGD P15428 4/20 0.42
HSD17B10 Q99714 3/20 0.42
ALOX15 P16050 1/20 0.42
KMT2A Q03164 2/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 2/20 0.40
BCHE P06276 2/20 0.39
SIRT5 Q9NXA8 1/20 0.39
CA12 O43570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6400218 0.89 TSHR (0.46) LMNATSHRTDP1ALDH1A1CYP3A4
SCHEMBL24707014 0.85 TDP1 (0.45) LMNATSHRTDP1ALDH1A1CYP3A4
SCHEMBL6399681 0.84 TDP1 (0.44) LMNATSHRTDP1ALDH1A1CYP3A4
SCHEMBL1902158 0.80 CYP3A4 (0.36) TSHRTDP1ALDH1A1CYP3A4CYP1A2
SCHEMBL27006194 0.80 CA12 (0.39) KMT2ACA12CA1CA2CA7
SCHEMBL8088582 0.80 LMNA (0.35) LMNATSHRTDP1ALDH1A1CYP3A4
SCHEMBL3671321 0.80 LMNA (0.46) LMNATSHRTDP1ALDH1A1CYP3A4
SCHEMBL1900001 0.79 ALDH1A1 (0.36) TSHRALDH1A1CYP3A4CYP1A2CYP2C9
SCHEMBL9618428 0.78 LMNA (0.45) LMNATSHRTDP1ALDH1A1CYP3A4
SCHEMBL27781086 0.78 LMNA (0.51) LMNATSHRTDP1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240019779-A1 COMPOUNDS AND PHOTORESIST COMPOSITIONS INCLUDING THE SAME U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2024-01-18 US disclosed
US-20240019779-A1 COMPOUNDS AND PHOTORESIST COMPOSITIONS INCLUDING THE SAME U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2024-01-18 US disclosed
US-20240019779-A1 COMPOUNDS AND PHOTORESIST COMPOSITIONS INCLUDING THE SAME U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2024-01-18 US disclosed
CN-117088795-A Compound and photoresist composition comprising the same 罗门哈斯电子材料有限责任公司 2023-11-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240019779-A1 COMPOUNDS AND PHOTORESIST COMPOSITIONS INCLUDING THE SAME CRY1, CCNT1, CCNA1 LMNA 915/4885TSHR 3135/4885TDP1 3055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.